For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230823:nRSW1141Ka&default-theme=true
RNS Number : 1141K Byotrol PLC 23 August 2023
RNS Reach
Byotrol plc
("Byotrol" or the "Company")
Investor Presentation via Investor Meet Company
Byotrol plc (AIM: BYOT), the specialist infection prevention and control
company is pleased to announce that Vivan Pinto, CEO, David Traynor,
Executive Director, and Chris Sedwell, CFO, will provide a live presentation
relating to the Full Year Results via Investor Meet Company on 8th Sep 2023
at 11:00am BST.
The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
9am the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to
meet BYOTROL PLC via:
https://www.investormeetcompany.com/byotrol-plc/register-investor
(https://protect-eu.mimecast.com/s/LhiuCKQw7tqvlN6uMCmC0?domain=investormeetcompany.com)
Investors who already follow BYOTROL PLC on the Investor Meet Company
platform will automatically be invited.
For further information, visit www.byotrolplc.com (http://www.byotrolplc.com)
, follow on twitter @byotrol, or contact
Byotrol Plc
Dr Trevor Francis, Non- Executive Chairman +44 (0)1925 742 000
Vivan Pinto, Chief Executive Officer
Chris Sedwell, Chief Financial Officer
finnCap Limited (Nominated Adviser and Broker) +44 (0)20 7220 0500
Geoff Nash/George Dollemore - Corporate Finance
Nigel Birks/Harriet Ward - ECM
Flagstaff Strategic and Investor Communications +44 (0)20 7129 1474
Tim Thompson/Andrea Seymour/Fergus Mellon byotrol@flagstaffcomms.com (mailto:byotrol@flagstaffcomms.com)
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention
and control company, operating globally in the Healthcare, Industrial, Food
and Consumer sectors, providing low toxicity products with a broad-based and
targeted efficacy across all microbial classes; bacteria, viruses (including
coronavirus), fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients within existing
products, where they can significantly improve their performance, especially
in personal hygiene, domestic and industrial disinfection, odour control, food
production and food management.
Byotrol develops and commercialises technologies that create easier, safer and
cleaner lives for everyone.
For more information, go to byotrol.com
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAPPUUPRUPWGWP